You can buy or sell STAAR and other stocks, options, ETFs, and crypto commission-free!
STAAR Surgical Co. engages in the development, manufacture, production, market, and trade of implantable lenses for the eye and delivery systems. It specializes in refractive and cataract solutions. Read More Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Monrovia, CA.
52 Week High
52 Week Low
Seeking AlphaMay 6
STAAR Surgical Company: Down On FDA Disclosure, But Not Out
Stock fell as much 22% on news of an FDA disclosure in its application to market 'EVO' lenses in the United States. Update, May 6, 2019, 2:10 p.m.: The title of this article has been updated from a previous version, which characterized the FDA disclosure as a rejection. STAAR Surgical Company (NASDAQ:STAA) has a 30-year history specializing in products for ophthalmic surgery and vision correction; first, for the treatment of cataracts going back to 1991, and the introduction of its revolutionary 'implanta...
Yahoo FinanceMay 2
Here’s What Hedge Funds Think About STAAR Surgical Company (STAA)
Insider Monkey finished processing more than 700 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of December 31st, 2018. What do these smart investors think about STAAR Surgical Company (NASDAQ:STAA)? STAAR Surgical Company (NASDAQ:STAA) investors should pay attention to a decrease in support from the world's most elite money managers in recent months. STAA was in 20 hedge funds' portfolios at the end of the fourth quarter of 2018. There ...
Expected Jul 31, After Hours